怀孕对生物假体结构的恶化的影响:系统性审查和元分析
Gianna L Wilkie1, Evelyn Semenov1, Katherine Leung1
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Obstetric medicine
|June 23, 2025
概括
怀孕史显著增加了生物假体门 (BPVs) 结构门恶化的风险. 这一系统性审查强调2.34的赔率增加,强调需要进一步调查这一关联.
科学领域:
- 心脏病学 心脏病学
- 生殖医学 生殖医学
- 生物医学工程 生物医学工程
背景情况:
- 生物假体门 (BPV) 越来越多地用于生育年龄的妇女.
- 怀孕对BPV长期耐用性的影响仍然是一个关键的临床问题.
- 结构损坏 (SVD) 是BPV长寿的一个主要问题.
研究的目的:
- 系统地审查和分析有关怀孕和SVD在患有BPVs的患者之间的关联的现有证据.
- 量化与没有怀孕史的个人相比,具有SVD的风险.
主要方法:
- 在主要数据库 (MEDLINE,Scopus,Clinicaltrials.gov,Cochrane Library) 进行了全面的文献搜索,截至2022年10月.
- 包括的研究比较了有妊娠史的BPV患者与没有妊娠史的患者.
- 随机效应的元分析是对来自九项合格研究的数据进行的.
主要成果:
- 分析包括了321名有怀孕史的个人和987名对照.
- 怀孕史与发展SVD的几率显著增加有关 (OR2.34,95% CI 1.40-3.89).
- 在包括的研究中注意到异质性 (I2 = 59.8%).
结论:
- 怀孕史与生物假体门结构损坏的风险更高有关.
- 这些发现表明怀孕对BPV耐久性的潜在不良影响.
- 鉴于观察到的异质性,需要进行进一步的研究来探索这种关联.
更多相关视频
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
11.5K
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
3.0K
相关概念视频
01:19Mitral Valve Prolapse III: Nursing Management
41
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
41
01:27Mitral Valve Prolapse I: Introduction
51
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
51
01:22Mitral Valve Prolapse II: Assessment and Management
48
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
48
01:26Mitral Stenosis III: Medical Management
29
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
29
01:27Mitral Stenosis IV: Nursing Management
51
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
51
01:25Mitral Regurgitation III: Medical Management
35
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
35